ALKS vs KLAC · P/E 14, rev $1.56B vs P/E 55, rev $12.16B
Alkermes Plc (ALKS) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the ALKS and KLAC stock pages for the full models.
Not investment advice.